Physician profile
Kenneth K Moghadam
NPI 1033120282
$8,353.87
in general payments reported to CMS, 2019-2025
7 companies · $7,084 in 2025
The $7,084 reported for 2025 was more than what 96% of Reproductive Endocrinology providers received nationally (typical 2025 total: $140).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $196 · 2021: $310 · 2022: $319 · 2023: $98.53 · 2024: $178 · 2025: $7,084.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,615 · Food and Beverage: $746.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,614.64 |
| Food and Beverage | $745.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $7,506.05 | 2020-2025 | Origio Sequential Fert, Stripper |
| Ferring Pharmaceuticals INC. | $340.65 | 2019-2025 | Menopur |
| Organon LLC | $242.48 | 2021-2025 | Pregnyl, Follistim Aq, Ganirelix Acetate |
| Emd Serono, INC. | $137.57 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $91.83 | 2019-2021 | |
| Abbvie INC. | $18.25 | 2025 | |
| Mission Pharmacal Company | $17.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Moghadam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.